VIOV:NYE-Vanguard S&P Small-Cap 600 Value Index Fund ETF Shares (USD)

ETF | Small Value |

Last Closing

USD 90.34

Change

-0.83 (-0.91)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Small Value

Symbol Name Price(Change) Market Cap
VBR Vanguard Small-Cap Value Index..

-1.46 (-0.73%)

USD 30.40B
IJS iShares S&P Small-Cap 600 Valu..

-1.12 (-1.06%)

USD 7.03B
DES WisdomTree U.S. SmallCap Divid..

-0.25 (-0.73%)

USD 2.04B
XSVM Invesco S&P SmallCap Value wit..

-0.39 (-0.72%)

USD 0.82B
XSLV Invesco S&P SmallCap Low Volat..

-0.45 (-0.95%)

USD 0.33B
RZV Invesco S&P SmallCap 600® Pur..

-1.12 (-1.03%)

N/A
JKL iShares Morningstar Small-Cap ..

N/A

N/A
SLYV SPDR® S&P 600 Small Cap Value..

-0.91 (-1.06%)

N/A
FDM First Trust Dow Jones Select M..

-0.70 (-1.11%)

N/A
PXSV Invesco S&P SmallCap Value wit..

-0.39 (-0.72%)

N/A

ETFs Containing VIOV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -48.96% 45% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.96% 45% F 10% F
Trailing 12 Months  
Capital Gain -39.92% 38% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -39.92% 38% F 11% F
Trailing 5 Years  
Capital Gain -27.55% 46% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.55% 46% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike